We surveyed all 50 state Medicaid programs. Three quarters of the states have very little coverage for obesity drugs. Eight different states told us they're considering it. The big studies, the most important studies that are coming is that both Eli Lilly and Novo Nordisk are the two makers.
Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek."
Hosted by Carol Massar and Madison Mills
Hear the show live at 3PM ET on WBBR 1130 AM New York, Bloomberg 106.1 FM Boston, Bloomberg 960 AM San Francisco, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 119, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.
You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno @MadisonMills22 and @BW
See omnystudio.com/listener for privacy information.